Veterinary Medicines

Supaverm Oral Suspension

Authorised
  • Mebendazole
  • Closantel sodium dihydrate
Download as PDF

Product identification

Medicine name:
Supaverm Oral Suspension
Active substance:
  • Mebendazole
  • Closantel sodium dihydrate
Target species:
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Mebendazole
    75.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Closantel sodium dihydrate
    54.37
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Meat and offal
        65
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC09
  • QP52AG09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • Container: Polyethylene bottles of 20 litres containing a white suspension.Closure: Ureum screw cap with HDPE insert.
  • Container: Polyethylene bottles of 10 litres containing a white suspension.Closure: Ureum screw cap with HDPE insert.
  • Container: Polyethylene bottles of 5 litres containing a white suspension.Closure: Ureum screw cap with HDPE insert.
  • Container: Polyethylene bottles of 2.5 litres containing a white suspension.Closure: Ureum screw cap with HDPE insert.
  • Container: Polyethylene bottles of 1 litre containing a white suspension.Closure: Ureum screw cap with HDPE insert.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Fixed combination application (Article 13b of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lusomedicamenta Sociedade Tecnica Farmaceutica S.A.
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA22020/031/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download